Best Stomach cancer stage 2 Doctors in Israel — TOP 19

Dr. Pelles Sharon specializes in stomach cancer surgery at Sourasky Medical Center (Ichilov), with expertise in advanced treatments like HIPEC and immunotherapy.

• Performs complex stomach cancer surgeries including Whipple procedures
• Pioneers Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for aggressive cases
• Offers immunotherapy options like Keytruda for targeted treatment
• Leads clinical research on oncologic patients' attitudes toward trials

Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center, with decades of specialized experience in stomach cancer.

• Associate Professor of Oncology at Tel-Aviv University
• Fellowship-trained at Institut Gustave Roussy in Paris
• Member of ESMO Sarcoma Faculty and ASCO
• Published extensively on cancer treatment outcomes

He leads a dedicated Cancer Prevention Center at Tel Aviv's Sourasky Medical Center, focusing on early detection and treatment of GI cancers.

• Over 44 years of experience of specialized experience in gastrointestinal (GI) tract oncology
• Head of the Integrated Cancer Prevention Center – one of Israel's leading cancer facilities
• Author of more than 300 research papers on cancer prevention and gene therapy
• Completed significant research work at NewYork-Presbyterian Center in the USA
• Member of key international societies like the European Society of Digestive Oncology

Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.

He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.

He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.

Prof. Ido Nachmany heads the Second Surgical Department at Sheba Medical Center. He specializes in HPB and robotic surgery for diseases of the liver, pancreas, and bile ducts, and for gastrointestinal neuroendocrine tumors. He also performs adrenal, spleen, and stomach surgery. Forbes listed him among Israel’s top physicians.

He advances minimally invasive robotic and laparoscopic techniques. The aim is better precision and faster recovery.

Credentials: Senior Lecturer at Tel Aviv University. Member of ASTS and IHPBA. Completed HPB and abdominal transplant fellowships at the Thomas E. Starzl Transplantation Institute. Board certified in General Surgery (Israel), Abdominal Organ Transplantation (ASTS), and HPB Surgery (University of Pittsburgh). He has published in Cancer Research, the Journal of the American College of Surgeons, and the European Journal of Surgical Oncology.

Dr. Almog Ben-Yaacov is an Attending Surgeon in the Department of General and Oncological Surgery (Surgery C) at Sheba Medical Center. He specializes in cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). His clinical focus includes gastric cancer, sarcoma, and complex colorectal malignancies. Since 2018, he has performed more than 200 HIPEC procedures.

MD, Semmelweis University, 2006, with honors. Training in cardiothoracic surgery at Sheba Medical Center. Residency in general surgery at Montefiore (Albert Einstein) and at Rabin (Beilinson). Board-certified in General Surgery and in Surgical Oncology.

Advanced training includes ESSO-certified HIPEC in Hamburg. Microwave liver ablation in Reims. NanoKnife at King’s College London. Advanced surgical oncology at Memorial Sloan Kettering (2019). His publications cover CRS+HIPEC outcomes and Hartmann’s reversal.

Dr. Einat Shacham‑Shmueli is a senior medical oncologist at the Gastrointestinal Clinic, Cancer Center, Sheba Medical Center. She treats cancers of the colon, stomach, and pancreas. She also manages metastatic disease. She uses precision diagnostics and biomarkers, systemic therapies, and radiotherapy. Care is provided within a multidisciplinary team.

She has authored more than 25 peer‑reviewed papers on GI oncology, tumor biology, and new treatments. Her work includes studies on stenting for malignant colonic obstruction. She serves as an investigator in international programs, including the NCI, the Radiation Therapy Oncology Group, and the Cancer Therapy Evaluation Program.

Education: MD, Tel Aviv University. Oncology residency, Tel Aviv Sourasky Medical Center. Advanced training in GI oncology, UCSF. Accreditations: Board certified in Oncology and Gastroenterology. Member, Israel Society of Oncology and Radiotherapy.

Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.

He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.

He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.

Leading the Israeli National Genomic Medicine Initiative – Dr. Raphael specializes in advanced genomic profiling for personalized stomach cancer treatment at Sourasky Medical Center.

• Senior Lecturer in Medical Oncology with extensive clinical trial leadership
• Expert in liquid biopsies and comprehensive genomic profiling
• PI for multiple innovative immunotherapy and chemotherapy studies
• Member of ESMO, IASLC, and other prestigious oncology societies
• Recipient of multiple teaching and research excellence awards

Dr. Wolf leads the Medical Oncology Division at the Sourasky Medical Center – a major Israeli teaching hospital with high expertise in complex cancer care.

• Specializes in medical oncology and internal medicine
• Fluent in English for international patients
• Holds a degree from Ben Gurion University
• Gained extensive clinical experience in the Army Medical Units

Dr. Stepfansky leads the oncology inpatient unit at Tel Aviv's leading hospital, Ichilov, and participates in clinical trials for the newest treatments.

• Over 26 years of experience of experience in internal medicine and oncology
• Directs inpatient cancer care at the Sourasky Medical Center
• Principal investigator for phase 1-3 clinical studies
• Extensive training completed at Ichilov Hospital in Tel Aviv

Heads the Colorectal Surgery Department at Sourasky Medical Center and is a top specialist in complex abdominal procedures.

• Over 35 years of experience of surgical experience
• Expert in both open and minimally invasive surgery
• Specializes in advanced techniques like the Whipple procedure

Dr. Alexander Beny leads the Gastrointestinal Malignant Service at Rambam Medical Center, specializing in stomach cancer treatment.

• Board-certified oncologist with extensive training in medical and radiation oncology
• Director of Gastrointestinal Malignant Service at Rambam Medical Center
• Fluent in English and Hebrew for international patients
• Completed specialized training in modern brachytherapy techniques

Professor Tamar Jablonski-Perec leads oncology at Hadassah Medical Center, with training at Sloan-Kettering Cancer Center in New York.

• Head of Institute of Oncology since 1994
• Specializes in breast cancer treatment
• Professor at Hebrew University's Department of Oncology
• Member of international cancer communities
• Awarded Hadassah Medical School scholarship

Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.

He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.

He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.

Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.

He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.